Literature DB >> 15179350

Ser128Arg gene polymorphism for E-selectin and severity of atherosclerotic arterial disease.

G Ghilardi1, M L Biondi, O Turri, E Guagnellini, R Scorza.   

Abstract

AIM: Genetic factors appear to be important in the pathogenesis of cardiovascular and cerebrovascular disease. Adhesion molecules like the members of the selectin family participate in the interaction between leukocytes and the endothelium. They are also involved in the pathogenesis of the atherosclerotic process. In E-selectin, exchange from serine to arginine (position 128, S128R) is correlated with early atherosclerosis. The aim of this study was to assess E-selectin Ser128Arg polymorphism in subjects with clinical and instrumental evidence of atherosclerosis and to analyze the correlations with clinical severity.
METHODS: A total of 144 subjects (100 men and 44 women, mean age 72 years, range 48-78) with atherosclerotic disease in different vascular sites documented by angiography were studied; 138 volunteers were recruited as a control group. Whole blood was collected; DNA was extracted with a commercial kit and amplified with 2 primers. The PCR was performed by standard procedure. To assess the disease severity all patients were classified by an arbitrary clinical and angiographic score scale.
RESULTS: The genotype distribution between patients and controls was different, although statistical significance was not achieved (p=0.06). In patients a significant difference in Arg allele frequency was observed between mild and severe atherosclerotic disease (OR 2.28; 95% CI 1.15-4.52; p=0.017). Four ho-mozygous cases for S128R were found in patients, none in controls. All these 4 patients had the highest severity score, that means a more severe atherosclerotic disease.
CONCLUSION: Our study suggests that the E-selectin polymorphism may be associated with severity of atherosclerotic disease, but does not allow us to conclude that it is actually a risk factor for atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179350

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

Review 1.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

2.  E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population.

Authors:  Zuoguang Wang; Ya Liu; Jieling Liu; Kuo Liu; Yuqin Lou; Jie Wen; Qiuli Niu; Shaojun Wen; Zhaosu Wu
Journal:  BMC Med Genet       Date:  2010-08-27       Impact factor: 2.103

3.  Association of E-selectin gene polymorphism (S128R) with ischemic stroke and stroke subtypes.

Authors:  Sitara Roy; Satrupa Das; Rakshith Danaboina; Vandana Sharma; Subhash Kaul; A Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

4.  Assessment of the E-selectin rs5361 (561A>C) polymorphism and soluble protein concentration in acute coronary syndrome: association with circulating levels.

Authors:  Elena Sandoval-Pinto; Jorge Ramon Padilla-Gutiérrez; Emmanuel Valdes-Alvarado; Ilian Janet García-González; Angelica Valdez-Haro; Jose Francisco Muñoz-Valle; Hector Enrique Flores-Salinas; Fernando Rivas; Yeminia Valle
Journal:  Mediators Inflamm       Date:  2014-07-24       Impact factor: 4.711

Review 5.  From Classical Laboratory Parameters to Novel Biomarkers for the Diagnosis of Venous Thrombosis.

Authors:  Larisa Anghel; Radu Sascău; Rodica Radu; Cristian Stătescu
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

6.  Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review.

Authors:  Dawn M Barnes; Thomas W Wakefield; John E Rectenwald
Journal:  Biomark Insights       Date:  2008-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.